Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,164 | 442 | 94.3% |
| Education | $288.42 | 4 | 3.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208.12 | 5 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,859 | 174 | $0 (2024) |
| Janssen Biotech, Inc. | $1,757 | 87 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $752.69 | 27 | $0 (2024) |
| Lilly USA, LLC | $567.75 | 30 | $0 (2024) |
| GENZYME CORPORATION | $561.59 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $406.91 | 20 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $363.94 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $265.48 | 19 | $0 (2024) |
| UCB, Inc. | $183.43 | 6 | $0 (2024) |
| LEO Pharma Inc. | $161.86 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,235 | 106 | ABBVIE INC. ($652.01) |
| 2023 | $1,789 | 105 | ABBVIE INC. ($603.80) |
| 2022 | $1,808 | 84 | ABBVIE INC. ($597.05) |
| 2021 | $981.59 | 60 | AbbVie Inc. ($345.60) |
| 2020 | $645.82 | 37 | AbbVie Inc. ($235.04) |
| 2019 | $539.11 | 26 | Regeneron Healthcare Solutions, Inc. ($159.02) |
| 2018 | $427.83 | 24 | AbbVie, Inc. ($250.56) |
| 2017 | $233.05 | 9 | Lilly USA, LLC ($99.96) |
All Payment Transactions
451 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.49 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.72 | General |
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Immunology | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Immunology | ||||||
| 09/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Immunology | ||||||
| 09/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 4,959 | 10,610 | $1.9M | $356,358 |
| 2022 | 33 | 5,401 | 10,621 | $2.1M | $416,594 |
| 2021 | 33 | 4,653 | 8,653 | $1.7M | $354,599 |
| 2020 | 33 | 4,512 | 9,011 | $1.2M | $314,421 |
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,294 | 1,817 | $539,649 | $105,248 | 19.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 879 | 1,212 | $270,276 | $42,637 | 15.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 471 | 544 | $205,632 | $40,444 | 19.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 431 | 508 | $171,704 | $31,626 | 18.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 701 | 5,104 | $117,392 | $24,863 | 21.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 71 | 76 | $76,836 | $16,386 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 188 | $78,960 | $15,650 | 19.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 102 | 127 | $71,374 | $14,839 | 20.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 144 | 144 | $53,136 | $9,158 | 17.2% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 43 | 44 | $38,632 | $7,931 | 20.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 128 | 175 | $29,400 | $6,446 | 21.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 44 | 52 | $25,584 | $4,715 | 18.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 41 | 41 | $33,333 | $3,840 | 11.5% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 18 | 18 | $18,558 | $3,798 | 20.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 26 | 29 | $17,226 | $3,556 | 20.6% |
| 12041 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.5 cm or less | Office | 2023 | 18 | 18 | $15,858 | $3,442 | 21.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 30 | 33 | $30,591 | $3,418 | 11.2% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 26 | 29 | $16,066 | $3,022 | 18.8% |
| 69100 | Biopsy of ear | Office | 2023 | 51 | 55 | $17,655 | $2,641 | 15.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 63 | 68 | $12,648 | $2,408 | 19.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 17 | 21 | $9,261 | $2,077 | 22.4% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 21 | 21 | $17,619 | $1,953 | 11.1% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 13 | 14 | $8,372 | $1,602 | 19.1% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 22 | $12,584 | $1,446 | 11.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 15 | $6,285 | $1,347 | 21.4% |
About Dr. Leslie Markle, MD
Dr. Leslie Markle, MD is a Dermatology healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2009. The National Provider Identifier (NPI) number assigned to this provider is 1225264443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leslie Markle, MD has received a total of $8,660 in payments from pharmaceutical and medical device companies, with $2,235 received in 2024. These payments were reported across 451 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($8,164).
As a Medicare-enrolled provider, Markle has provided services to 19,525 Medicare beneficiaries, totaling 38,895 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Tyler, TX
- Active Since 06/02/2009
- Last Updated 08/04/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1225264443
Products in Payments
- TREMFYA (Drug) $1,620
- SKYRIZI (Biological) $1,187
- DUPIXENT (Biological) $1,145
- RINVOQ (Biological) $751.89
- TALTZ (Drug) $449.65
- Humira (Biological) $408.95
- Sotyktu (Drug) $234.54
- COSENTYX (Biological) $200.38
- ILUMYA (Biological) $179.60
- ADBRY (Biological) $161.86
- SURGIPRO LL (Device) $144.20
- HUMIRA (Biological) $143.88
- EUCRISA (Drug) $125.00
- Otezla (Drug) $101.36
- LIBTAYO (Biological) $92.62
- REMICADE (Biological) $86.30
- BLU-U (Medical Supply) $76.27
- Cimzia (Drug) $67.00
- Seysara (Drug) $61.06
- STELARA (Biological) $57.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Tyler
Jennifer Holman, Md, MD
Dermatology — Payments: $705,235
Lindsey Hunter-Ellul, Md, MD
Dermatology — Payments: $11,358
Martha Mccollough, Md, MD
Dermatology — Payments: $10,842
Alma Berlingeri Ramos, Md, MD
Dermatology — Payments: $4,757
Jeffrey Harbold, Do, DO
Dermatology — Payments: $4,013
Bradley Graham, Md, MD
Dermatology — Payments: $3,625